Developing Medical Device Technologies Payers and End Users Will Adopt
While new technologies are developed at a rapid pace, providers and payers may remain slow to adopt them for a number of reasons. Key to adoption of new devices is sufficient data demonstrating effectiveness, safety and value. Catering to the needs and concerns of payers and end users can be challenging. Fortunately, quality research and a well-formulated market strategy can lead to earlier market adoption and widespread usage of new devices.
AUTHOR: Elizabeth Brooks
Mobile Medical Applications (MMAs)
Mobile communication devices are radically changing the way we think and make decisions about our health care. Medical device and biopharmaceutical companies are increasingly looking for avenues to innovate and demonstrate improved clinical outcomes, while manufacturers are beginning to embrace MMAs as part of their clinical development and business strategies.
AUTHORS: Elizabeth Brooks, Prithul Bom
Companion Diagnostics: Important Health Economics and Reimbursement Considerations
An essential component of precision medicine (PM) is the use of molecular diagnostics to aid in detection of biomarkers to either confirm the presence of disease or determine which patients will respond to available disease treatment alternatives. The promise of PM is that patients with a disease will be identified earlier and receive targeted treatment to obtain the best outcome in the shortest possible time.
AUTHORS: Elizabeth Brooks, Felicia Bergstrom